| UN Global Compact Principles |
GRI core indicators (version G3) |
Coverage |
Links |
|
Vision and strategy |
|
|
| 1-10 |
1.1 |
Statement from the CEO or Chairman of the Supervisory Board |
Complete |
|
|
1.2 |
Key sustainability impacts, risks and opportunities |
Complete |
|
|
Organizational profile |
|
|
|
2.1 |
Name of the company |
Complete |
|
|
2.2 |
Major brands, products and services |
Complete |
|
|
2.3 |
Business areas and operational structure |
Complete |
|
|
2.4 |
Location of company’s headquarters |
Complete |
|
|
2.5 |
Countries in which the organization’s main operations are located |
Complete |
|
|
2.6 |
Nature of ownership |
Complete |
|
|
2.7 |
Markets |
Complete |
|
|
2.8 |
Scale of the company |
Complete |
|
|
2.9 |
Significant changes during the reporting period |
Complete |
|
|
2.10 |
Awards received in the reporting period |
Complete |
|
|
Reporting parameters |
|
|
|
3.1 |
Reporting period |
Complete |
2010 |
|
3.2 |
Date of most recent previous report |
Complete |
May 2010 |
|
3.3 |
Reporting cycle |
Complete |
annually |
|
3.4 |
Contact for questions regarding the report |
Complete |
|
|
3.5 |
Process for defining report content |
Complete |
|
|
3.6 |
Limits of the reporting procedure |
Complete |
|
|
3.7 |
Limitations on the scope of the report |
Complete |
|
|
3.8 |
Joint ventures, subsidiaries, outsourcing |
Complete |
|
|
3.9 |
Data capture |
Complete |
|
|
3.10 |
Changes in the presentation of information compared to earlier reports |
Complete |
|
|
3.11 |
Changes in the scope and limitations of the report or in the measurement methods applied |
Complete |
|
|
3.12 |
Index according to GRI |
Complete |
|
|
3.13 |
Verification: external verification of the statements |
Complete |
|
|
Management, obligations and commitment |
|
|
| 1-10 |
4.1 |
Governance structure |
Complete |
|
|
4.2 |
Independence of the Supervisory Board Chairman |
Complete |
|
|
4.3 |
Governance body and/or independent members of management |
Complete |
|
|
4.4 |
Mechanisms for stockholders and employees to provide recommendations to the Board of Management or Supervisory Board |
Complete |
|
|
4.5 |
Linkage between Board of Management compensation and company performance |
Complete |
|
|
4.6 |
Mechanisms in place to ensure avoidance of conflicts of interest |
Complete |
|
| 1-10 |
4.7 |
Expertise of the governance bodies in sustainability issues |
Complete |
|
| 1-10 |
4.8 |
Mission statements, company values and codes of conduct |
Complete |
|
|
4.9 |
Procedures of the Board of Management and Supervisory Board for overseeing sustainability performance |
Complete |
|
|
4.10 |
Processes for evaluating the performance of the Board of Management |
Complete |
|
| 7 |
4.11 |
Implementation of the precautionary principle |
Complete |
|
| 1-10 |
4.12 |
Support of external initiatives |
Complete |
|
|
4.13 |
Principal memberships in industry and business associations |
Complete |
|
| 1-10 |
4.14 |
Stakeholder groups engaged by the organization |
Complete |
|
|
4.15 |
Selection of stakeholders |
Complete |
|
|
4.16 |
Approaches to stakeholder dialogue (type/frequency) |
Complete |
|
| 1-10 |
4.17 |
Statements on key concerns raised by stakeholders |
Complete |
|
| 1, 4, 6, 7 |
Economic performance indicators – Management approach |
Complete |
|
|
EC1 |
Economic value generated and distributed |
Complete |
|
| 7 |
EC2 |
Financial implications of climate change |
Complete |
|
| 1 |
EC3 |
Defined company benefit plan obligations |
Complete |
|
|
EC4 |
Public service financial benefits |
Complete |
|
|
EC6 |
Business policy towards local suppliers |
Complete |
|
| 6 |
EC7 |
Senior management hired from the local community |
Complete |
|
|
EC8 |
Infrastructure investments and services provided for public benefit |
Complete |
|
| 7, 8, 9 |
Ecological performance indicators – Management approach |
Complete |
|
| 8, 9 |
EN1 |
Materials used by weight/volume* |
This indicator has only relevance for part of our business, weight/volumne of renewable resources is not reported. This is caused by Bayer's diverse company structure which sets up procurement units per subgroup, not centrally. If it makes sense from a technical, economic and ecological viewpoint, we favor the use of renewable raw materials, although this still does not play a major part in terms of our total raw material consumption.
Partial |
|
| 8, 9 |
EN2 |
Percentage of materials used that are recycled input materials* |
This indicator has only relevance for part of our business .The weight or volume of recycled input materials as a percentage of the total input materials is not reported in quantitative figures. Throughout the Group, we encourage extensive recycling.However, this is not possible for a large proportion of our end products, owing to legal requirements, particularly for pharmaceuticals and crop protection agents.
Partial |
|
| 8 |
EN3 / 4 |
Direct/indirect energy consumption by primary energy sources |
Complete |
|
| 8 |
EN8 |
Total water withdrawal by source |
Complete |
|
| 8 |
EN11 |
Biodiversity: use of land in protected areas |
Complete |
|
| 8 |
EN12 |
Biodiversity: significant impacts of activities in protected areas |
Complete |
|
| 8, 9 |
EN16 |
Direct and indirect greenhouse gas emissions |
Complete |
|
| 8 |
EN17 |
Other relevant greenhouse gas emissions |
Complete |
|
| 7, 8, 9 |
EN18 |
Initiatives to reduce greenhouse gas emissions and reductions achieved |
Complete |
|
| 8 |
EN19 |
Emissions of ozone-depleting substances by weight |
Complete |
|
| 8 |
EN20 |
NOx, SOx, and other significant air emissions by weight |
Complete |
|
| 8 |
EN21 |
Wastewater discharge |
Complete |
|
| 8 |
EN22 |
Waste by type and disposal method |
Complete |
|
| 8 |
EN23 |
Releases of hazardous substances by number and volume |
Complete |
|
| 7, 8, 9 |
EN26 |
Initiatives to mitigate environmental impacts of products and services |
Complete |
|
|
EN27 |
Percentage of products and packaging which is reused |
Not relevant |
This indicator only has no relevance for our business. The percentage of packaging materials is not reported. Throughout the Group, we encourage extensive recycling. However, this is not possible for a large proportion of our end products, owing to legal requirements, particularly for pharmaceuticals and crop protection agents.
indicator is not reported |
|
EN28 |
Fines/Sanctions for non-compliance with environmental regulations |
Complete |
|
| 1, 3, 6 |
Social performance indicators |
Complete |
|
|
Working conditions – Management approach |
Complete |
|
|
LA1 |
Breakdown of workforce by employment type and region |
Complete |
|
| 6 |
LA2 |
Workforce fluctuation by age group, gender and region* |
Bayer monitors the age the employees’ fluctuation (age-wise) due to the demographical change, but not completely systematically. So far, turn over figures for gender and age group (the total and rate per region) are not available yet.
Partial |
|
| 1, 3 |
LA4 |
Percentage of employees covered by collective wage agreements |
Complete |
|
| 1, 3 |
LA5 |
Minimum notice period(s) regarding significant operational changes |
Complete |
|
| 1 |
LA7 |
Injuries, absenteeism and fatalities |
Complete |
|
| 1 |
LA8 |
Risk control and programs with respect to serious diseases |
Complete |
|
|
LA10 |
Training and continuing education hours by employee category* |
In terms of education and trainings we do not focus on average hours per training. We report other figures, such as vocational and ongoing training expenses per year.
Partial |
|
|
LA11 |
Programs for employability and lifelong learning |
Complete |
|
| 1, 6 |
LA13 |
Composition of senior management and employee structure (e.g. age/gender/culture) |
Complete |
|
| 1, 6 |
LA14 |
Compensation by gender and employee category* |
The remuneration of men and women is a central aspect of equality of opportunity. At Bayer, equality naturally applies to the remuneration of employees. Individual salaries are based on each employee’s personal and professional abilities and the level of responsibility assigned to them.
Partial |
|
|
Human rights – Management approach |
Complete |
|
| 1-6 |
HR1 |
Investment decisions that include human rights clauses or screening |
Complete |
|
| 1-6 |
HR2 |
Percentage of suppliers that undergo screening on human rights |
Complete |
|
| 1-6 |
HR3 |
Employee training on human rights* |
Complete |
|
| 1, 2, 6 |
HR4 |
Incidents of discrimination and action taken |
Complete |
|
| 1-5 |
HR5-7 |
Freedom of association and right to collective bargaining; child labor, forced labor; businesses with significant risk |
Complete |
|
|
Society – Management approach |
Complete |
|
|
SO1 |
Policy to manage impacts on local communities |
Complete |
|
| 10 |
SO2 |
Corruption: percentage and number of business areas analyzed* |
We aim for a group wide coverage, not separated per business unit.
Partial |
|
| 10 |
SO3 |
Corruption: percentage of employees trained in corruption prevention |
Complete |
|
| 10 |
SO4 |
Action taken in response to incidents of corruption |
Complete |
|
| 1-10 |
SO5 |
Political affairs: public policy positions and participation in public policy development and lobbying |
Complete |
|
|
SO8 |
Legal compliance: fines / sanctions for non-compliance with regulations |
Complete |
|
|
Product stewardship – Management approach |
Complete |
|
| 1, 8 |
PR1 |
Product life cycle stages for which health and safety impacts are assessed |
Complete |
|
| 8 |
PR3 |
Principles/measures related to product labeling |
Complete |
|
|
PR6 |
Programs for compliance with laws and voluntary codes related to advertising |
Complete |
|
|
PR9 |
Significant fines for non-compliance with laws and regulations concerning the use of products and services |
Complete |
|